Remove 2013 Remove Drug Pricing Remove Vaccines
article thumbnail

Streamlining bioprocessing for gene therapy

European Pharmaceutical Review

Single-use bioprocessing technologies enabling more rapid vaccines production [Internet]. He was named Head of Process Development in 2013, then promoted to Chief Scientific Officer (CSO) in 2020. million for Hemgenix [AAV5-hFIX-Padua]). Available from: [link] Nielsen J, Tillegreen CB, Petranovic D. Trends in Biotechnology.

article thumbnail

Medicare Price “Negotiations” Will Jeopardize Patient Access to New Medicines, Result in Worse Health Outcomes

Safe Biologics

September 11, 2023 The Centers for Medicare & Medicaid Services (CMS) recently announced the first 10 drugs selected under its Medicare drug price “negotiation” plan, authorized by the Inflation Reduction Act (IRA) signed in to law last year. 1] 90% of new cancer drugs are available in the U.S.